Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance

Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by cancer cells themselves through activation of de novo synthesis pathways, they orchestrate a large variety of pro-tumorigenic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogenesis (New York, NY) Jg. 11; H. 1; S. 46 - 15
Hauptverfasser: Vasseur, Sophie, Guillaumond, Fabienne
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 09.08.2022
Nature Publishing Group
Nature Publishing Group: Open Access Journals - Option C
Schlagworte:
13
38
631/67/2327
631/67/327
64
64/110
96
Adipocytes
Antibodies
Apoptosis
Cancer
Cell activation
Cell Biology
Cholesterol
Fatty acids
Fibroblasts
Glycerol
Human Genetics
Immunotherapy
Internal Medicine
Life Sciences
Lipids
Medicine
Medicine & Public Health
Metabolism
Metabolites
Metastases
Metastasis
Oncology
Oxidation
Review
Review Article
Treatment resistance
Tumor microenvironment
Tumors
Cancer metabolism
Cancer microenvironment
ISSN:2157-9024, 2157-9024
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by cancer cells themselves through activation of de novo synthesis pathways, they orchestrate a large variety of pro-tumorigenic functions. Importantly, TME cells, especially immune cells, cancer-associated fibroblasts (CAFs) and cancer-associated adipocytes (CAAs), are also prone to changes in their lipid content, which hinder or promote tumor aggressiveness. In this review, we address the significant findings for lipid contribution in tumor progression towards a metastatic disease and in the poor response to therapeutic treatments. We also highlight the benefits of targeting lipid pathways in preclinical models to slow down metastasis development and overcome chemo-and immunotherapy resistance.
AbstractList Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by cancer cells themselves through activation of de novo synthesis pathways, they orchestrate a large variety of pro-tumorigenic functions. Importantly, TME cells, especially immune cells, cancer-associated fibroblasts (CAFs) and cancer-associated adipocytes (CAAs), are also prone to changes in their lipid content, which hinder or promote tumor aggressiveness. In this review, we address the significant findings for lipid contribution in tumor progression towards a metastatic disease and in the poor response to therapeutic treatments. We also highlight the benefits of targeting lipid pathways in preclinical models to slow down metastasis development and overcome chemo-and immunotherapy resistance.
Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by cancer cells themselves through activation of de novo synthesis pathways, they orchestrate a large variety of pro-tumorigenic functions. Importantly, TME cells, especially immune cells, cancer-associated fibroblasts (CAFs) and cancer-associated adipocytes (CAAs), are also prone to changes in their lipid content, which hinder or promote tumor aggressiveness. In this review, we address the significant findings for lipid contribution in tumor progression towards a metastatic disease and in the poor response to therapeutic treatments. We also highlight the benefits of targeting lipid pathways in preclinical models to slow down metastasis development and overcome chemo-and immunotherapy resistance.Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by cancer cells themselves through activation of de novo synthesis pathways, they orchestrate a large variety of pro-tumorigenic functions. Importantly, TME cells, especially immune cells, cancer-associated fibroblasts (CAFs) and cancer-associated adipocytes (CAAs), are also prone to changes in their lipid content, which hinder or promote tumor aggressiveness. In this review, we address the significant findings for lipid contribution in tumor progression towards a metastatic disease and in the poor response to therapeutic treatments. We also highlight the benefits of targeting lipid pathways in preclinical models to slow down metastasis development and overcome chemo-and immunotherapy resistance.
Abstract Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by cancer cells themselves through activation of de novo synthesis pathways, they orchestrate a large variety of pro-tumorigenic functions. Importantly, TME cells, especially immune cells, cancer-associated fibroblasts (CAFs) and cancer-associated adipocytes (CAAs), are also prone to changes in their lipid content, which hinder or promote tumor aggressiveness. In this review, we address the significant findings for lipid contribution in tumor progression towards a metastatic disease and in the poor response to therapeutic treatments. We also highlight the benefits of targeting lipid pathways in preclinical models to slow down metastasis development and overcome chemo-and immunotherapy resistance.
ArticleNumber 46
Author Vasseur, Sophie
Guillaumond, Fabienne
Author_xml – sequence: 1
  givenname: Sophie
  orcidid: 0000-0002-2339-8854
  surname: Vasseur
  fullname: Vasseur, Sophie
  organization: Centre de Recherche en Cancérologie de Marseille, INSERM, Aix-Marseille Université, CNRS, Institut Paoli-Calmettes
– sequence: 2
  givenname: Fabienne
  orcidid: 0000-0001-7456-7315
  surname: Guillaumond
  fullname: Guillaumond, Fabienne
  email: fabienne.guillaumond@inserm.fr
  organization: Centre de Recherche en Cancérologie de Marseille, INSERM, Aix-Marseille Université, CNRS, Institut Paoli-Calmettes
BackLink https://amu.hal.science/hal-03962099$$DView record in HAL
BookMark eNp9kk1v1DAQhiNUREvpH-BkiQscAuOvfHBAqiqglVbi0rvlOJNdrxJ7sb1b9d_jbIqge2gujsbP-86r8bwtzpx3WBTvKXymwJsvUVDetCUwVgIIBmXzqrhgVNZlC0yc_fd_XlzFuIX8yYpWUr4pzrlshWTAL4rDyu5sH4l1xGhnMHwlmqxH3-mRHCw-ED-QtEFivEvBdvtkvZtr4ywjO502D_oxkuTJhEnHpJM1ZPBh0kdSu56kgDpN6BIJGG1Gcpt3xetBjxGvns7L4v7H9_ub23L16-fdzfWqNFLSVNYaKGsak7M3FUdaGdn3EhmtKesE9Ax0iwabmgsJbKg60xvElncdDpUc-GVxt9j2Xm_VLthJh0fltVXHgg9rpUNOPKKqkfcUWA1VxYUWomuASdC6oU2N0Ins9W3x2u27CXOfPBA9PjN9fuPsRq39QbU8O1aQDT4tBpsT2e31Ss014G3FoG0PNLMfn5oF_3uPManJRoPjqB36fVQ5J1QChJxzfThBt34fXJ7qkcqjammTqWahTPAxBhyUsen4RjmrHRUFNa-VWtZK5bVSx7VSs5SdSP-Gf1HEF1HMsFtj-JfqBdUfKkLftw
CitedBy_id crossref_primary_10_3389_fphar_2024_1442723
crossref_primary_10_3390_biomedicines11071786
crossref_primary_10_3892_ol_2024_14715
crossref_primary_10_1073_pnas_2307780121
crossref_primary_10_1016_j_nut_2024_112357
crossref_primary_10_1016_j_drudis_2024_103980
crossref_primary_10_18632_oncotarget_28755
crossref_primary_10_1016_j_chemphyslip_2022_105269
crossref_primary_10_1016_j_neo_2025_101143
crossref_primary_10_1021_jasms_3c00195
crossref_primary_10_1007_s10120_023_01436_8
crossref_primary_10_1080_00325481_2024_2370235
crossref_primary_10_3389_fphar_2024_1514811
crossref_primary_10_1186_s12935_023_03138_8
crossref_primary_10_3389_fimmu_2023_1295684
crossref_primary_10_1016_j_semcancer_2024_12_002
crossref_primary_10_1093_biolre_ioae170
crossref_primary_10_1186_s40478_024_01796_x
crossref_primary_10_3390_cancers14215224
crossref_primary_10_1186_s13048_024_01389_1
crossref_primary_10_3892_ijo_2024_5713
crossref_primary_10_1038_s41598_025_05898_x
crossref_primary_10_3390_cancers15030994
crossref_primary_10_1002_1878_0261_13582
crossref_primary_10_31083_j_fbl2904137
crossref_primary_10_3390_ijms24098441
crossref_primary_10_1002_1878_0261_13583
crossref_primary_10_1016_j_ccr_2025_216889
crossref_primary_10_1038_s44303_025_00077_z
crossref_primary_10_3389_fonc_2024_1424293
crossref_primary_10_3390_ijms252111384
crossref_primary_10_1016_j_ctarc_2025_100953
crossref_primary_10_1002_cnr2_2078
crossref_primary_10_1186_s12929_024_01095_6
crossref_primary_10_3390_ijms26073322
crossref_primary_10_1002_adma_202309582
crossref_primary_10_1038_s41568_022_00537_3
crossref_primary_10_1002_smtd_202200898
crossref_primary_10_3892_ijmm_2024_5361
crossref_primary_10_1083_jcb_202402035
crossref_primary_10_1038_s41523_025_00784_1
crossref_primary_10_3390_ijms24097820
crossref_primary_10_1186_s12885_024_12519_9
crossref_primary_10_1016_j_bbalip_2025_159679
crossref_primary_10_3389_fphar_2023_1163160
crossref_primary_10_1186_s13046_023_02832_9
crossref_primary_10_1038_s41698_024_00662_2
crossref_primary_10_1111_febs_70081
crossref_primary_10_1016_j_apsb_2024_07_021
crossref_primary_10_1016_j_biomaterials_2023_122353
crossref_primary_10_1016_j_tranon_2024_101913
crossref_primary_10_1186_s12944_024_02140_x
crossref_primary_10_3390_ijms26189132
crossref_primary_10_1016_j_cstres_2025_100092
crossref_primary_10_1159_000539412
crossref_primary_10_1039_D4NR04926H
crossref_primary_10_3390_cancers15225465
crossref_primary_10_1002_anie_202401195
crossref_primary_10_52082_jssm_2024_366
crossref_primary_10_1038_s41389_025_00575_0
crossref_primary_10_1186_s12935_024_03481_4
crossref_primary_10_1016_j_tranon_2024_102250
crossref_primary_10_1016_j_tranon_2024_102095
crossref_primary_10_1038_s41598_024_55458_y
crossref_primary_10_1038_s43856_024_00589_6
crossref_primary_10_1186_s12967_025_06657_2
crossref_primary_10_1186_s12967_024_05091_0
crossref_primary_10_1007_s00740_025_00548_4
crossref_primary_10_1186_s40170_024_00349_z
crossref_primary_10_3390_metabo15040221
crossref_primary_10_3390_metabo12111057
crossref_primary_10_3390_metabo13070872
crossref_primary_10_3390_nursrep13040126
crossref_primary_10_1186_s12885_023_11771_9
crossref_primary_10_1002_advs_202503233
crossref_primary_10_3389_fimmu_2024_1468957
crossref_primary_10_1016_j_biochi_2024_01_018
crossref_primary_10_3390_nu16091265
crossref_primary_10_3390_cancers16132473
crossref_primary_10_1002_ange_202401195
crossref_primary_10_1007_s00292_024_01368_9
crossref_primary_10_3390_cancers15153898
crossref_primary_10_1038_s41417_023_00695_y
crossref_primary_10_3389_fmolb_2023_1235160
crossref_primary_10_1007_s12020_024_03767_7
crossref_primary_10_1038_s41586_025_09017_8
crossref_primary_10_1080_14737140_2025_2492784
crossref_primary_10_1016_j_bbcan_2025_189318
crossref_primary_10_3389_fimmu_2025_1580222
crossref_primary_10_1002_adma_202312528
crossref_primary_10_1016_j_celrep_2024_115206
crossref_primary_10_1016_j_yexcr_2025_114452
crossref_primary_10_1016_j_drudis_2023_103628
Cites_doi 10.1038/nm.2492
10.1158/0008-5472.CAN-16-0651
10.1002/cam4.2474
10.1111/j.1365-2249.2010.04167.x
10.1158/2159-8290.CD-19-1353
10.1038/nm.2172
10.1158/1541-7786.MCR-17-0665
10.1038/s41467-017-00910-z
10.1016/j.cell.2015.08.015
10.2741/2692
10.1038/s41388-020-01432-7
10.1038/s42255-021-00493-6
10.1158/0008-5472.CAN-20-1255
10.1038/s41590-020-0783-5
10.1080/15384101.2019.1676581
10.1038/onc.2014.85
10.1158/1078-0432.CCR-19-0253
10.1038/s41568-020-00320-2
10.1038/s41580-018-0085-z
10.3389/fonc.2020.581457
10.1158/2159-8290.CD-16-0441
10.1136/gutjnl-2015-309304
10.1088/2057-1739/aa7e86
10.1038/s41467-020-17339-6
10.1016/j.bbabio.2020.148300
10.3389/fendo.2020.591819
10.3389/fphys.2012.00344
10.1097/MOL.0000000000000443
10.1038/nature17412
10.3389/fonc.2022.795159
10.1016/j.cmet.2019.04.002
10.1038/s41388-020-1207-6
10.1038/s41467-017-02186-9
10.1038/s41588-017-0027-2
10.1016/j.canlet.2018.04.038
10.3389/fonc.2020.01510
10.1016/j.immuni.2019.06.017
10.1073/pnas.1421601112
10.1016/j.trecan.2020.03.001
10.1158/0008-5472.CAN-07-0199
10.1038/s41467-018-04987-y
10.1073/pnas.1703791114
10.1158/2326-6066.CIR-15-0036
10.1371/journal.pone.0193318
10.1016/j.ccell.2014.12.002
10.1038/s41416-018-0327-z
10.1073/pnas.1612920114
10.1016/j.drup.2020.100682
10.3389/fphar.2019.00836
10.1084/jem.20130440
10.1016/j.cmet.2014.01.019
10.1073/pnas.1613332113
10.1158/2159-8290.CD-18-1212
10.1016/j.cell.2009.11.027
10.1016/j.addr.2020.07.013
10.1158/0008-5472.CAN-09-3871
10.1158/0008-5472.CAN-11-1261
10.1016/j.cmet.2019.11.010
10.1038/ncomms8064
10.1038/onc.2016.168
10.1038/s41467-017-02732-5
10.1016/j.ccell.2017.08.004
10.1016/j.celrep.2019.11.008
10.1172/JCI148550
10.1038/s41392-020-0134-x
10.1371/journal.pone.0079633
10.1038/s41590-019-0589-5
10.1016/j.immuni.2021.05.003
10.1158/0008-5472.CAN-18-0921
10.1158/0008-5472.CAN-20-3929
10.1002/cphy.c120023
10.1038/s41573-021-00367-2
10.3390/molecules25173935
10.1126/science.aav0173
10.2147/ITT.S306109
10.1158/0008-5472.CAN-18-1487
10.1016/j.biocel.2019.105610
10.1158/0008-5472.CAN-19-1999
10.1158/0008-5472.CAN-19-2843
10.1158/1541-7786.MCR-19-0756
10.1016/j.cell.2016.01.021
10.1158/0008-5472.CAN-07-6161
10.1016/j.ccell.2016.05.012
10.1038/cddis.2017.21
10.15252/embj.2019102525
10.1172/JCI127755
10.1038/nrc.2016.89
10.1016/j.plipres.2020.101055
10.1038/nature16140
10.1016/j.cell.2018.01.004
10.1016/j.freeradbiomed.2017.04.013
10.1158/2159-8290.CD-12-0031
10.1038/s41568-021-00388-4
10.1016/j.bbrc.2017.02.003
10.1038/nature14034
10.1038/s41416-019-0650-z
10.1016/j.cmet.2019.02.016
10.1210/er.2010-0013
10.1038/s43018-021-00183-y
10.1016/j.cmet.2019.06.001
10.1038/s41388-017-0093-z
10.1016/j.cmet.2021.02.015
10.1038/nm.2074
10.1016/j.jhep.2017.06.015
10.1016/j.ebiom.2018.11.045
10.1158/0008-5472.CAN-16-3062
10.1158/0008-5472.CAN-15-1970
10.1016/j.plipres.2016.09.002
10.1038/s41586-021-03235-6
10.1038/nature10602
10.1002/jcp.30229
10.1016/j.bbcan.2016.12.004
10.1038/nrm2330
10.1016/j.trecan.2019.09.007
10.1038/nature12297
10.1038/nrc2809
10.1016/j.trecan.2021.02.004
10.1002/ijc.31868
10.1016/j.canlet.2017.06.022
10.1038/s41568-019-0238-1
10.1038/srep14752
10.1053/j.gastro.2019.11.013
10.1038/srep09054
10.1080/2162402X.2017.1344804
10.1038/s41586-019-1118-2
10.1016/j.immuni.2017.12.004
10.3389/fimmu.2017.01124
10.3389/fimmu.2018.02927
10.1016/j.canlet.2019.12.036
10.1016/j.molcel.2019.09.008
10.1016/j.canlet.2018.03.034
10.1073/pnas.1720113115
10.1158/0008-5472.CAN-18-3295
10.4049/jimmunol.0802740
10.1038/s41388-018-0570-z
10.1158/2159-8290.CD-20-0844
10.1016/j.molcel.2018.01.001
10.1177/1010428320941760
10.1152/ajpendo.90926.2008
10.1016/j.ccell.2020.08.015
10.1038/nri3789
10.1158/2326-6066.CIR-16-0400
10.1186/s40170-020-00237-2
10.1038/s41586-020-2969-2
10.1038/cddis.2017.152
10.1038/nature20791
10.1038/nrm2336
10.1002/ijc.31392
10.1210/en.2016-1570
10.4049/jimmunol.1700544
ContentType Journal Article
Copyright The Author(s) 2022
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022. The Author(s).
Attribution
Copyright_xml – notice: The Author(s) 2022
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022. The Author(s).
– notice: Attribution
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
1XC
VOOES
5PM
DOA
DOI 10.1038/s41389-022-00420-8
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Science Database (subscription)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2157-9024
EndPage 15
ExternalDocumentID oai_doaj_org_article_7e3d102706634a44b80250aa8187e0b4
PMC9363460
oai:HAL:hal-03962099v1
10_1038_s41389_022_00420_8
GrantInformation_xml – fundername: French National Cancer Institute (Pair Pancreas 2018-082) French foundation for Cancer Research (PGA 2020, PJA-20181208127) GEFLUC Marseille Provence & Canceropole PACA
– fundername: ;
GroupedDBID 0R~
3V.
53G
5VS
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBLON
EBS
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
CITATION
7XB
8FK
K9.
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
1XC
VOOES
5PM
ID FETCH-LOGICAL-c551t-7a01288c000863e16c5dd5e21712b40d20a9ece8734502f6bcdcee93bbef65f3
IEDL.DBID DOA
ISICitedReferencesCount 112
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000838082400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2157-9024
IngestDate Fri Oct 03 12:50:50 EDT 2025
Tue Nov 04 02:01:05 EST 2025
Tue Oct 14 20:16:08 EDT 2025
Sun Nov 09 12:55:58 EST 2025
Sat Nov 29 14:55:14 EST 2025
Tue Nov 18 22:15:45 EST 2025
Sat Nov 29 02:53:39 EST 2025
Fri Feb 21 02:40:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Cancer metabolism
Cancer microenvironment
Language English
License Attribution: http://creativecommons.org/licenses/by
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c551t-7a01288c000863e16c5dd5e21712b40d20a9ece8734502f6bcdcee93bbef65f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-2339-8854
0000-0001-7456-7315
OpenAccessLink https://doaj.org/article/7e3d102706634a44b80250aa8187e0b4
PMID 35945203
PQID 2700171918
PQPubID 2041913
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_7e3d102706634a44b80250aa8187e0b4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9363460
hal_primary_oai_HAL_hal_03962099v1
proquest_miscellaneous_2700640454
proquest_journals_2700171918
crossref_citationtrail_10_1038_s41389_022_00420_8
crossref_primary_10_1038_s41389_022_00420_8
springer_journals_10_1038_s41389_022_00420_8
PublicationCentury 2000
PublicationDate 2022-08-09
PublicationDateYYYYMMDD 2022-08-09
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-09
  day: 09
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: New York
PublicationTitle Oncogenesis (New York, NY)
PublicationTitleAbbrev Oncogenesis
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Publishing Group: Open Access Journals - Option C
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Publishing Group: Open Access Journals - Option C
References Helms, Onate, Sherman (CR74) 2020; 10
Pacella, Procaccini, Focaccetti, Miacci, Timperi, Faicchia (CR99) 2018; 115
Butler, Perone, Dehairs, Lupien, de Laat, Talebi (CR6) 2020; 159
Cen, Lang, Du, Wei, Xiong, Bradley (CR41) 2020; 158
Rodriguez-Aguayo, Bayraktar, Ivan, Aslan, Mai, He (CR138) 2019; 40
Kalafati, Mitroulis, Verginis, Chavakis, Kourtzelis (CR106) 2020; 10
Li, Qu, Tian, Zhang, Cheng (CR144) 2018; 13
Sunshine, Iruela-Arispe (CR1) 2017; 28
Nomura, Long, Niessen, Hoover, Ng, Cravatt (CR28) 2010; 140
Corn, Windham, Rafat (CR9) 2020; 80
Prima, Kaliberova, Kaliberov, Curiel, Kusmartsev (CR94) 2017; 114
Lim, Wei, Nguyen, Shi, Su, Palacios (CR100) 2021; 591
Röhrig, Schulze (CR31) 2016; 16
Gabitova-Cornell, Surumbayeva, Peri, Franco-Barraza, Restifo, Weitz (CR61) 2020; 38
Baek, Yu, He, Wardell, Chang, Kwon (CR69) 2017; 8
Neesse, Algül, Tuveson, Gress (CR72) 2015; 64
Pascual, Avgustinova, Mejetta, Martín, Castellanos, Attolini (CR22) 2017; 541
Krzeszinski, Schwaid, Cheng, Jin, Gallegos, Saghatelian (CR47) 2016; 158
Jiang, Fang, Wang, Li, Wang (CR103) 2018; 9
Veglia, Tyurin, Mohammadyani, Blasi, Duperret, Donthireddy (CR105) 2017; 8
Ma, Lau, Leung, Lo, Ho, Cheng (CR135) 2017; 67
Carter, Mak, Wang, Tao, Ruvolo, Mak (CR142) 2019; 79
Mutemberezi, Guillemot-Legris, Muccioli (CR51) 2016; 64
Zerbinati, Iuliano (CR67) 2017; 111
Kitamura, Qian, Pollard (CR82) 2015; 15
Hoy, Nagarajan, Butler (CR12) 2021; 21
Zhao, Hao, Wang, Li, Meng, Li (CR57) 2019; 38
Satpathy, Jala, Bodduluri, Krishnan, Hegde, Hoyle (CR109) 2015; 6
Xue, Qi, Zhang, Ding, Huang, Zhao (CR53) 2020; 10
Papaevangelou, Almeida, Box, deSouza, Chung (CR131) 2018; 143
Montero, Morales, Llacuna, Lluis, Terrones, Basañez (CR145) 2008; 68
Soncini, Corna, Moresco, Coltella, Restuccia, Maggioni (CR108) 2016; 113
Feng, Wilkins, Bang, Ung, Li, An (CR126) 2019; 29
Hennequart, Pilotte, Cane, Hoffmann, Stroobant, Plaen (CR150) 2017; 5
Hou, Sampath, Rojas, Thorne (CR151) 2016; 30
Veglia, Tyurin, Blasi, De Leo, Kossenkov, Donthireddy (CR110) 2019; 569
Ma, Xiao, Liu, Ye, Su, Bi (CR115) 2021; 33
Markosyan, Li, Sun, Richman, Lin, Yan (CR113) 2019; 129
Basu, Whitlock, Husson, Le Floc’h, Jin, Oyler-Yaniv (CR112) 2016; 165
Hajeyah, Griffiths, Wang, Finch, O'Donnell (CR66) 2020; 11
Wen, Liu, Li, Li, Gao, Shao (CR91) 2015; 34
Grabner, Xie, Schweiger, Zechner (CR27) 2021; 3
Salunkhe, Mishra, Ghorai, Hole, Chandrani, Dutt (CR129) 2020; 1861
Nieman, Kenny, Penicka, Ladanyi, Buell-Gutbrod, Zillhardt (CR18) 2011; 17
Chen, Zhang, Sampieri, Clohessy, Mendez, Gonzalez-Billalabeitia (CR38) 2018; 50
Villablanca, Raccosta, Zhou, Fontana, Maggioni, Negro (CR102) 2010; 16
Mondal, Roy, Bhattacharya, Jin, Jung, Zhang (CR137) 2019; 144
Nath, Li, Roberts, Chan (CR23) 2015; 5
Sethunath, Hu, De Angelis, Veeraraghavan, Qin, Wang (CR147) 2019; 17
Seager, Hajal, Spill, Kamm, Zaman (CR81) 2017; 3
Wang, Lu, Wang, Wang, He, Wu (CR130) 2020; 473
Snaebjornsson, Janaki-Raman, Schulze (CR13) 2020; 31
Wang, Yao, Rao, Zheng, Chen (CR70) 2019; 54
Pranzini, Pardella, Paoli, Fendt, Taddei (CR124) 2021; 7
Zelenay, van der Veen, Böttcher, Snelgrove, Rogers, Acton (CR85) 2015; 162
Ferraro, Ali, Luengo, Kodack, Deik, Abbott (CR37) 2021; 2
Martinez, Sica, Mantovani, Locati (CR90) 2008; 13
Lee, Jeong, Jang, Bae, Kim, Park (CR25) 2019; 363
Clement, Lazar, Attané, Carrié, Dauvillier, Ducoux-Petit (CR80) 2020; 39
Giraldo, Sanchez-Salas, Peske, Vano, Becht, Petitprez (CR73) 2019; 120
Zhao, Xiao, Evans, Theivanthiran, DeVito, Holtzhausen (CR149) 2018; 48
Zhang, Kurupati, Liu, Zhou, Zhang, Hudaihed (CR117) 2017; 32
Cotte, Aires, Fredon, Limagne, Derangère, Thibaudin (CR136) 2018; 9
Batchuluun, Pinkosky, Steinberg (CR34) 2022; 21
Liu, Gao, Yang, Zhao, Guo, Sun (CR89) 2022; 12
Maione, Oliaro-Bosso, Meda, Di Nicolantonio, Bussolino, Balliano (CR60) 2015; 5
Xu, Chaudhary, Rodríguez-Morales, Sun, Chen, Zappasodi (CR116) 2021; 54
Fares, Fares, Khachfe, Salhab, Fares (CR15) 2020; 5
Paul, Lal (CR120) 2017; 8
Dallavalle, Dobričić, Lazzarato, Gazzano, Machuqueiro, Pajeva (CR122) 2020; 50
Porta, Consonni, Morlacchi, Sangaletti, Bleve, Totaro (CR84) 2020; 80
Wang, Zhang, Chen (CR123) 2019; 2
Wang, Dubois (CR39) 2010; 10
Farge, Saland, de Toni, Aroua, Hosseini, Perry (CR128) 2017; 7
Apte, Pirola, Wilson (CR75) 2012; 3
Lemberg, Gori, Tsukamoto, Rais, Slusher (CR134) 2022; 132
Mahata, Pramanik, van der Weyden, Polanski, Kar, Riedel (CR101) 2020; 11
Nosaka, Baba, Tanabe, Sasaki, Nishimura, Imamura (CR45) 2018; 200
Nagarajan, Butler, Hoy (CR7) 2021; 9
Wang, Franco, Tsui, Xie, Trefny, Zappasodi (CR98) 2020; 21
Riscal, Skuli, Simon (CR8) 2019; 76
Karmakar, Pal, Lal (CR119) 2021; 10
Metallo, Gameiro, Bell, Mattaini, Yang, Hiller (CR33) 2011; 481
Jiang, Wang, Song, Liu, Gu, Xu (CR58) 2019; 79
Jin, Demere, Nair, Ali, Ferraro, Natoli (CR36) 2020; 588
Al-Khami, Zheng, Valle, Hossain, Wyczechowska, Zabaleta (CR87) 2017; 6
Morandi, Indraccolo (CR125) 2017; 1868
Dieli, Vermijlen, Fulfaro, Caccamo, Meraviglia, Cicero (CR152) 2007; 67
Wculek, Malanchi (CR44) 2015; 528
Li, Gu, Lee, Song, Bandyopadhyay, Chen (CR64) 2016; 35
Olzmann, Carvalho (CR26) 2019; 20
Chen, Zhang, Xian, Lv, Lin, Wang (CR71) 2017; 484
Herber, Cao, Nefedova, Novitskiy, Nagaraj, Tyurin (CR104) 2010; 16
Wright, Hou, Xu, Cortez, Potma, Tromberg (CR30) 2017; 114
Gharpure, Pradeep, Sans, Rupaimoole, Ivan, Wu (CR19) 2018; 9
Bergers, Fendt (CR16) 2021; 21
Wei, Qian, Yu, Wong (CR17) 2020; 39
Jung, Ko, Um, Chinnathambi, Alharbi, Sethi (CR59) 2021; 236
Chang, Li, Chang, Urano (CR62) 2009; 297
Ostrand-Rosenberg, Sinha (CR83) 2009; 182
Meraviglia, Eberl, Vermijlen, Todaro, Buccheri, Cicero (CR153) 2010; 161
Lazar, Clement, Dauvillier, Milhas, Ducoux-Petit, LeGonidec (CR79) 2016; 76
Guillaumond, Bidaut, Ouaissi, Servais, Gouirand, Olivares (CR143) 2015; 112
Lin, Li, Zhou, Li, Wang, Luo (CR140) 2019; 116
Koundouros, Poulogiannis (CR4) 2020; 122
Mukherjee, Chiang, Daifotis, Nieman, Fahrmann, Lastra (CR20) 2020; 80
Dillekås, Rogers, Straume (CR14) 2019; 8
Sahai, Astsaturov, Cukierman, DeNardo, Egeblad, Evans (CR76) 2020; 20
Chen, Fu, Luo, Chen, Cheng, Zhang (CR42) 2017; 8
Tadros, Shukla, King, Gunda, Vernucci, Abrego (CR133) 2017; 77
Liu, Chikina, Deshpande, Menk, Wang, Tabib (CR96) 2019; 51
Hossain, Al-Khami, Wyczechowska, Hernandez, Zheng, Reiss (CR86) 2015; 3
Raccosta, Fontana, Maggioni, Lanterna, Villablanca, Paniccia (CR107) 2013; 210
Fhu, Ali (CR35) 2020; 25
Sukhanova, Gorin, Serebriiskii, Gabitova, Zheng, Restifo (CR148) 2013; 3
Rysman, Brusselmans, Scheys, Timmermans, Derua, Munck (CR132) 2010; 70
Wen, Xing, Harris, Zaytseva, Mitov, Napier (CR77) 2017; 8
Wang, Attané, Milhas, Dirat, Dauvillier, Guerard (CR78) 2017; 23
Cirmena, Franceschelli, Isnaldi, Ferrando, De Mariano, Ballestrero (CR54) 2018; 425
Rozeveld, Johnson, Zhang, Razidlo (CR29) 2020; 80
Chiang (CR50) 2013; 3
Attané, Muller (CR11) 2020; 6
Goossens, Rodriguez-Vita, Etzerodt, Masse, Rastoin, Gouirand (CR93) 2019; 29
Silvente-Poirot, Dalenc, Poirot (CR68) 2018; 78
Ma, Bi, Lu, Su, Huang, Liu (CR114) 2019; 30
Wang, Jing, Xu, Liao, Song, Sun (CR43) 2020; 39
Aloia, Müllhaupt, Chabbert, Eberhart, Flückiger-Mangual, Vukolic (CR127) 2019; 25
Li, Lu, Shi, Gong, Hua, Li (CR46) 2020; 21
Li, Wang, Zheng, Guan, Yang, Chen (CR24) 2018; 69
Auciello, Bulusu, Oon, Tait-Mulder, Berry, Bhattacharyya (CR10) 2019; 9
Schug, Peck, Jones, Zhang, Grosskurth, Alam (CR32) 2015; 27
Miller, Auchus (CR49) 2011; 32
Lee, Li, Vickman, Li, Liu, Durkes (CR63) 2018; 16
Peck, Schulze (CR5) 2019; 5
Poczobutt, Gijon, Amin, Hanson, Li, Walker (CR111) 2013; 8
Lin, Luo, Wang, Li, Huang, Chen (CR139) 2019; 10
Ladanyi, Mukherjee, Kenny, Johnson, Mitra, Sundaresan (CR21) 2018; 37
Matusewicz, Czogalla, Sikorski (CR52) 2020; 42
Zhao, Prijic, Urban, Tisza, Zuo, Li (CR55) 2016; 76
Yang, Qin, Chen, Yuan, Song, Wang (CR56) 2018; 429
Zeng, Yang, Cloer, Neale, Vogel, Chi (CR97) 2013; 499
Yang, Bai, Xiong, Zhang, Chen, Zheng (CR118) 2016; 531
Kemp, Carpenter, Steele, Donahue, Nwosu, Pacheco (CR92) 2021; 81
Daurkin, Eruslanov, Stoffs, Perrin, Algood, Gilbert (CR95) 2011; 71
Kurtova, Xiao, Mo, Pazhanisamy, Krasnow, Lerner (CR141) 2015; 517
Fu, He, Qi, Chen, Luo, Chen (CR40) 2017; 403
Fendt, Frezza, Erez (CR3) 2020; 10
Zhang, Liu, Duan, Wang, Zhang, Qiao (CR146) 2019; 18
Yue, Li, Lee, Lee, Shao, Song (CR65) 2014; 19
Ikonen (CR48) 2008; 9
Vitale, Manic, Coussens, Kroemer, Galluzzi (CR88) 2019; 30
van Meer, Voelker, Feigenson (CR2) 2008; 9
Böttcher, Bonavita, Chakravarty, Blees, Cabeza-Cabrerizo, Sammicheli (CR121) 2018; 172
H Fu (420_CR40) 2017; 403
I Vitale (420_CR88) 2019; 30
AK Cotte (420_CR136) 2018; 9
YY Jung (420_CR59) 2021; 236
MT Snaebjornsson (420_CR13) 2020; 31
JY Krzeszinski (420_CR47) 2016; 158
NA Giraldo (420_CR73) 2019; 120
S Mondal (420_CR137) 2019; 144
J Li (420_CR144) 2018; 13
S Silvente-Poirot (420_CR68) 2018; 78
L Matusewicz (420_CR52) 2020; 42
E Papaevangelou (420_CR131) 2018; 143
E Helms (420_CR74) 2020; 10
E Sahai (420_CR76) 2020; 20
W Yang (420_CR118) 2016; 531
X-X Li (420_CR24) 2018; 69
L Chen (420_CR42) 2017; 8
YY Wang (420_CR78) 2017; 23
AJ Hoy (420_CR12) 2021; 21
KM Lemberg (420_CR134) 2022; 132
SK Wculek (420_CR44) 2015; 528
L Kalafati (420_CR106) 2020; 10
B Batchuluun (420_CR34) 2022; 21
A Mukherjee (420_CR20) 2020; 80
C-K Lee (420_CR25) 2019; 363
S Ostrand-Rosenberg (420_CR83) 2009; 182
L Jiang (420_CR103) 2018; 9
Z Wen (420_CR91) 2015; 34
E Pranzini (420_CR124) 2021; 7
SR Satpathy (420_CR109) 2015; 6
W Hou (420_CR151) 2016; 30
B Mahata (420_CR101) 2020; 11
FR Auciello (420_CR10) 2019; 9
MV Apte (420_CR75) 2012; 3
Z Zhao (420_CR57) 2019; 38
M Soncini (420_CR108) 2016; 113
Y Zhang (420_CR117) 2017; 32
KM Gharpure (420_CR19) 2018; 9
G Pascual (420_CR22) 2017; 541
CW Fhu (420_CR35) 2020; 25
P Goossens (420_CR93) 2019; 29
J Montero (420_CR145) 2008; 68
F Zhao (420_CR149) 2018; 48
X Lin (420_CR140) 2019; 116
V Sethunath (420_CR147) 2019; 17
AA Al-Khami (420_CR87) 2017; 6
D Wang (420_CR39) 2010; 10
SA Lim (420_CR100) 2021; 591
S Jiang (420_CR58) 2019; 79
W Zhao (420_CR55) 2016; 76
X Wang (420_CR123) 2019; 2
CM Metallo (420_CR33) 2011; 481
GB Ferraro (420_CR37) 2021; 2
S Salunkhe (420_CR129) 2020; 1861
H Dillekås (420_CR14) 2019; 8
AE Baek (420_CR69) 2017; 8
Z Yang (420_CR56) 2018; 429
X Lin (420_CR139) 2019; 10
S Dallavalle (420_CR122) 2020; 50
GF Grabner (420_CR27) 2021; 3
V Mutemberezi (420_CR51) 2016; 64
SR Nagarajan (420_CR7) 2021; 9
S Tadros (420_CR133) 2017; 77
C Rodriguez-Aguayo (420_CR138) 2019; 40
L Chen (420_CR71) 2017; 484
KM Nieman (420_CR18) 2011; 17
R Basu (420_CR112) 2016; 165
G Bergers (420_CR16) 2021; 21
FO Martinez (420_CR90) 2008; 13
E Clement (420_CR80) 2020; 39
J Liu (420_CR89) 2022; 12
Y-A Wen (420_CR77) 2017; 8
MKF Ma (420_CR135) 2017; 67
ZT Schug (420_CR32) 2015; 27
S Yue (420_CR65) 2014; 19
C Attané (420_CR11) 2020; 6
Q Wei (420_CR17) 2020; 39
DL Herber (420_CR104) 2010; 16
HJ Lee (420_CR63) 2018; 16
M Hennequart (420_CR150) 2017; 5
E Ikonen (420_CR48) 2008; 9
I Daurkin (420_CR95) 2011; 71
F Veglia (420_CR105) 2017; 8
G Cirmena (420_CR54) 2018; 425
L Xue (420_CR53) 2020; 10
M Chen (420_CR38) 2018; 50
AV Kurtova (420_CR141) 2015; 517
J Fares (420_CR15) 2020; 5
JA Olzmann (420_CR26) 2019; 20
C Liu (420_CR96) 2019; 51
H Wang (420_CR98) 2020; 21
S-M Fendt (420_CR3) 2020; 10
F Dieli (420_CR152) 2007; 67
A Aloia (420_CR127) 2019; 25
X Ma (420_CR114) 2019; 30
F Hossain (420_CR86) 2015; 3
C Porta (420_CR84) 2020; 80
BZ Carter (420_CR142) 2019; 79
A Sukhanova (420_CR148) 2013; 3
J Li (420_CR64) 2016; 35
DK Nomura (420_CR28) 2010; 140
H Sunshine (420_CR1) 2017; 28
S Meraviglia (420_CR153) 2010; 161
N Markosyan (420_CR113) 2019; 129
S Karmakar (420_CR119) 2021; 10
X Ma (420_CR115) 2021; 33
A Nath (420_CR23) 2015; 5
T Nosaka (420_CR45) 2018; 200
I Pacella (420_CR99) 2018; 115
T-Y Chang (420_CR62) 2009; 297
WW Feng (420_CR126) 2019; 29
F Röhrig (420_CR31) 2016; 16
H Zeng (420_CR97) 2013; 499
JYL Chiang (420_CR50) 2013; 3
JM Poczobutt (420_CR111) 2013; 8
S Xu (420_CR116) 2021; 54
P Li (420_CR46) 2020; 21
WL Miller (420_CR49) 2011; 32
RJ Seager (420_CR81) 2017; 3
EJ Villablanca (420_CR102) 2010; 16
T Farge (420_CR128) 2017; 7
B Cen (420_CR41) 2020; 158
S Wang (420_CR70) 2019; 54
G van Meer (420_CR2) 2008; 9
S Zelenay (420_CR85) 2015; 162
V Prima (420_CR94) 2017; 114
N Koundouros (420_CR4) 2020; 122
C Zerbinati (420_CR67) 2017; 111
F Maione (420_CR60) 2015; 5
F Veglia (420_CR110) 2019; 569
LM Butler (420_CR6) 2020; 159
I Lazar (420_CR79) 2016; 76
E Rysman (420_CR132) 2010; 70
KC Corn (420_CR9) 2020; 80
HJ Wright (420_CR30) 2017; 114
T Kitamura (420_CR82) 2015; 15
T Wang (420_CR43) 2020; 39
R Riscal (420_CR8) 2019; 76
JP Böttcher (420_CR121) 2018; 172
AA Hajeyah (420_CR66) 2020; 11
L Raccosta (420_CR107) 2013; 210
B Peck (420_CR5) 2019; 5
SB Kemp (420_CR92) 2021; 81
F Guillaumond (420_CR143) 2015; 112
Y Zhang (420_CR146) 2019; 18
A Ladanyi (420_CR21) 2018; 37
A Morandi (420_CR125) 2017; 1868
CN Rozeveld (420_CR29) 2020; 80
L Gabitova-Cornell (420_CR61) 2020; 38
X Jin (420_CR36) 2020; 588
S Paul (420_CR120) 2017; 8
Y Wang (420_CR130) 2020; 473
A Neesse (420_CR72) 2015; 64
References_xml – volume: 17
  start-page: 1498
  year: 2011
  end-page: 503
  ident: CR18
  article-title: Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
  publication-title: Nat Med
  doi: 10.1038/nm.2492
– volume: 76
  start-page: 4051
  year: 2016
  end-page: 7
  ident: CR79
  article-title: Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-0651
– volume: 8
  start-page: 5574
  year: 2019
  end-page: 6
  ident: CR14
  article-title: Are 90% of deaths from cancer caused by metastases?
  publication-title: Cancer Med
  doi: 10.1002/cam4.2474
– volume: 161
  start-page: 290
  year: 2010
  end-page: 7
  ident: CR153
  article-title: In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2010.04167.x
– volume: 2
  start-page: 141
  year: 2019
  end-page: 60
  ident: CR123
  article-title: Drug resistance and combating drug resistance in cancer
  publication-title: Cancer Drug Resist
– volume: 10
  start-page: 648
  year: 2020
  end-page: 56
  ident: CR74
  article-title: Fibroblast heterogeneity in the pancreatic tumor microenvironment
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-19-1353
– volume: 16
  start-page: 880
  year: 2010
  end-page: 6
  ident: CR104
  article-title: Lipid accumulation and dendritic cell dysfunction in cancer
  publication-title: Nat Med
  doi: 10.1038/nm.2172
– volume: 16
  start-page: 974
  year: 2018
  end-page: 85
  ident: CR63
  article-title: Cholesterol esterification inhibition suppresses prostate cancer metastasis by impairing the Wnt/β-catenin pathway
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-17-0665
– volume: 8
  year: 2017
  ident: CR69
  article-title: The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-00910-z
– volume: 162
  start-page: 1257
  year: 2015
  end-page: 70
  ident: CR85
  article-title: Cyclooxygenase-dependent tumor growth through evasion of immunity
  publication-title: Cell
  doi: 10.1016/j.cell.2015.08.015
– volume: 54
  start-page: 966
  year: 2019
  end-page: 80
  ident: CR70
  article-title: 25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-κB signaling pathway
  publication-title: Int J Oncol
– volume: 13
  start-page: 453
  year: 2008
  end-page: 61
  ident: CR90
  article-title: Macrophage activation and polarization
  publication-title: Front Biosci
  doi: 10.2741/2692
– volume: 39
  start-page: 6139
  year: 2020
  end-page: 56
  ident: CR17
  article-title: Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications
  publication-title: Oncogene
  doi: 10.1038/s41388-020-01432-7
– volume: 3
  start-page: 1445
  year: 2021
  end-page: 65
  ident: CR27
  article-title: Lipolysis: cellular mechanisms for lipid mobilization from fat stores
  publication-title: Nat Metab
  doi: 10.1038/s42255-021-00493-6
– volume: 80
  start-page: 4932
  year: 2020
  end-page: 4945
  ident: CR29
  article-title: KRAS controls pancreatic cancer cell lipid metabolism and invasive potential through the lipase HSL
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-20-1255
– volume: 21
  start-page: 1444
  year: 2020
  end-page: 55
  ident: CR46
  article-title: Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis
  publication-title: Nat Immunol
  doi: 10.1038/s41590-020-0783-5
– volume: 18
  start-page: 3337
  year: 2019
  end-page: 50
  ident: CR146
  article-title: Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2019.1676581
– volume: 34
  start-page: 1241
  year: 2015
  end-page: 52
  ident: CR91
  article-title: Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration
  publication-title: Oncogene
  doi: 10.1038/onc.2014.85
– volume: 25
  start-page: 6852
  year: 2019
  end-page: 67
  ident: CR127
  article-title: A fatty acid oxidation-dependent metabolic shift regulates the adaptation of BRAF-mutated melanoma to MAPK Inhibitors
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-19-0253
– volume: 21
  start-page: 162
  year: 2021
  end-page: 80
  ident: CR16
  article-title: The metabolism of cancer cells during metastasis
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-020-00320-2
– volume: 20
  start-page: 137
  year: 2019
  end-page: 55
  ident: CR26
  article-title: Dynamics and functions of lipid droplets
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-018-0085-z
– volume: 10
  start-page: 581457.
  year: 2020
  ident: CR106
  article-title: Neutrophils as orchestrators in tumor development and metastasis formation
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.581457
– volume: 7
  start-page: 716
  year: 2017
  end-page: 35
  ident: CR128
  article-title: Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-16-0441
– volume: 64
  start-page: 1476
  year: 2015
  end-page: 84
  ident: CR72
  article-title: Stromal biology and therapy in pancreatic cancer: a changing paradigm
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-309304
– volume: 3
  start-page: 034002
  year: 2017
  ident: CR81
  article-title: Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression
  publication-title: Converg Sci Phys Oncol
  doi: 10.1088/2057-1739/aa7e86
– volume: 11
  year: 2020
  ident: CR101
  article-title: Tumors induce de novo steroid biosynthesis in T cells to evade immunity
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-17339-6
– volume: 1861
  start-page: 148300
  year: 2020
  ident: CR129
  article-title: Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics
  publication-title: Biochim Biophys Acta Bioenerg
  doi: 10.1016/j.bbabio.2020.148300
– volume: 11
  start-page: 591819.
  year: 2020
  ident: CR66
  article-title: The biosynthesis of enzymatically oxidized lipids
  publication-title: Front Endocrinol
  doi: 10.3389/fendo.2020.591819
– volume: 3
  start-page: 344
  year: 2012
  ident: CR75
  article-title: Pancreatic stellate cells: a starring role in normal and diseased pancreas
  publication-title: Front Physiol
  doi: 10.3389/fphys.2012.00344
– volume: 28
  start-page: 408
  year: 2017
  end-page: 13
  ident: CR1
  article-title: Membrane lipids and cell signaling
  publication-title: Curr Opin Lipido
  doi: 10.1097/MOL.0000000000000443
– volume: 531
  start-page: 651
  year: 2016
  end-page: 5
  ident: CR118
  article-title: Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism
  publication-title: Nature
  doi: 10.1038/nature17412
– volume: 12
  start-page: 795159.
  year: 2022
  ident: CR89
  article-title: Macrophages and metabolic reprograming in the tumor microenvironment
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.795159
– volume: 30
  start-page: 143
  year: 2019
  end-page: .e5
  ident: CR114
  article-title: Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.04.002
– volume: 39
  start-page: 3179
  year: 2020
  end-page: 94
  ident: CR43
  article-title: PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model
  publication-title: Oncogene
  doi: 10.1038/s41388-020-1207-6
– volume: 8
  year: 2017
  ident: CR105
  article-title: Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-02186-9
– volume: 50
  start-page: 206
  year: 2018
  end-page: 18
  ident: CR38
  article-title: An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
  publication-title: Nat Genet
  doi: 10.1038/s41588-017-0027-2
– volume: 429
  start-page: 66
  year: 2018
  end-page: 77
  ident: CR56
  article-title: Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2018.04.038
– volume: 10
  start-page: 1510.10.
  year: 2020
  ident: CR53
  article-title: Targeting SREBP-2-regulated mevalonate metabolism for cancer therapy
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.01510
– volume: 51
  start-page: 381
  year: 2019
  end-page: .e6
  ident: CR96
  article-title: Treg cells promote the SREBP1-dependent metabolic fitness of tumor-promoting macrophages via repression of CD8+ T cell-derived interferon-γ
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.06.017
– volume: 112
  start-page: 2473
  year: 2015
  end-page: 8
  ident: CR143
  article-title: Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
  publication-title: PNAS
  doi: 10.1073/pnas.1421601112
– volume: 6
  start-page: 593
  year: 2020
  end-page: 604
  ident: CR11
  article-title: Drilling for oil: tumor-surrounding adipocytes fueling cancer
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2020.03.001
– volume: 67
  start-page: 7450
  year: 2007
  end-page: 7
  ident: CR152
  article-title: Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-0199
– volume: 9
  year: 2018
  ident: CR19
  article-title: FABP4 as a key determinant of metastatic potential of ovarian cancer
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-04987-y
– volume: 114
  start-page: E6556
  year: 2017
  end-page: E6565.
  ident: CR30
  article-title: CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1703791114
– volume: 3
  start-page: 1236
  year: 2015
  end-page: 47
  ident: CR86
  article-title: Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-15-0036
– volume: 13
  start-page: e0193318
  year: 2018
  ident: CR144
  article-title: Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0193318
– volume: 27
  start-page: 57
  year: 2015
  end-page: 71
  ident: CR32
  article-title: Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2014.12.002
– volume: 120
  start-page: 45
  year: 2019
  end-page: 53
  ident: CR73
  article-title: The clinical role of the TME in solid cancer
  publication-title: Br J Cancer
  doi: 10.1038/s41416-018-0327-z
– volume: 114
  start-page: 1117
  year: 2017
  end-page: 22
  ident: CR94
  article-title: COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
  publication-title: PNAS
  doi: 10.1073/pnas.1612920114
– volume: 50
  start-page: 100682
  year: 2020
  ident: CR122
  article-title: Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
  publication-title: Drug Resist Updates
  doi: 10.1016/j.drup.2020.100682
– volume: 10
  start-page: 836.
  year: 2019
  ident: CR139
  article-title: The role of prostaglandin-endoperoxide synthase-2 in chemoresistance of non-small cell lung cancer
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2019.00836
– volume: 210
  start-page: 1711
  year: 2013
  end-page: 28
  ident: CR107
  article-title: The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
  publication-title: J Exp Med
  doi: 10.1084/jem.20130440
– volume: 19
  start-page: 393
  year: 2014
  end-page: 406
  ident: CR65
  article-title: Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2014.01.019
– volume: 113
  start-page: E6219
  year: 2016
  end-page: E6227
  ident: CR108
  article-title: 24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development
  publication-title: PNAS
  doi: 10.1073/pnas.1613332113
– volume: 9
  start-page: 617
  year: 2019
  end-page: 27
  ident: CR10
  article-title: A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-18-1212
– volume: 140
  start-page: 49
  year: 2010
  end-page: 61
  ident: CR28
  article-title: Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.027
– volume: 159
  start-page: 245
  year: 2020
  end-page: 93
  ident: CR6
  article-title: Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2020.07.013
– volume: 70
  start-page: 8117
  year: 2010
  end-page: 26
  ident: CR132
  article-title: De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3871
– volume: 71
  start-page: 6400
  year: 2011
  end-page: 9
  ident: CR95
  article-title: Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-Lipoxygenase-2 pathway
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-1261
– volume: 31
  start-page: 62
  year: 2020
  end-page: 76
  ident: CR13
  article-title: Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.11.010
– volume: 6
  year: 2015
  ident: CR109
  article-title: Crystalline silica-induced leukotriene B 4 -dependent inflammation promotes lung tumour growth
  publication-title: Nat Commun
  doi: 10.1038/ncomms8064
– volume: 35
  start-page: 6378
  year: 2016
  end-page: 88
  ident: CR64
  article-title: Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2016.168
– volume: 9
  year: 2018
  ident: CR136
  article-title: Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-02732-5
– volume: 32
  start-page: 377
  year: 2017
  end-page: .e9
  ident: CR117
  article-title: Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.08.004
– volume: 29
  start-page: 3405
  year: 2019
  end-page: .e5
  ident: CR126
  article-title: CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2019.11.008
– volume: 132
  start-page: e148550.132.
  year: 2022
  ident: CR134
  article-title: Clinical development of metabolic inhibitors for oncology
  publication-title: J Clin Invest
  doi: 10.1172/JCI148550
– volume: 5
  start-page: 28
  year: 2020
  ident: CR15
  article-title: Molecular principles of metastasis: a hallmark of cancer revisited
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-0134-x
– volume: 8
  start-page: e79633
  year: 2013
  ident: CR111
  article-title: Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0079633
– volume: 21
  start-page: 298
  year: 2020
  end-page: 308
  ident: CR98
  article-title: CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
  publication-title: Nat Immunol
  doi: 10.1038/s41590-019-0589-5
– volume: 54
  start-page: 1561
  year: 2021
  end-page: .e7
  ident: CR116
  article-title: Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.05.003
– volume: 79
  start-page: 1165
  year: 2019
  end-page: 77
  ident: CR142
  article-title: An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-0921
– volume: 81
  start-page: 4305
  year: 2021
  end-page: 18
  ident: CR92
  article-title: Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-κB–mediated production of CXCL1
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-20-3929
– volume: 3
  start-page: 1191
  year: 2013
  end-page: 212
  ident: CR50
  article-title: Bile acid metabolism and signaling
  publication-title: Compr Physiol
  doi: 10.1002/cphy.c120023
– volume: 21
  start-page: 283
  year: 2022
  end-page: 305
  ident: CR34
  article-title: Lipogenesis inhibitors: therapeutic opportunities and challenges
  publication-title: Nat Rev Drug Disco
  doi: 10.1038/s41573-021-00367-2
– volume: 25
  start-page: E3935
  year: 2020
  ident: CR35
  article-title: Fatty acid synthase: an emerging target in cancer
  publication-title: Molecules
  doi: 10.3390/molecules25173935
– volume: 363
  start-page: 644
  year: 2019
  end-page: 9
  ident: CR25
  article-title: Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation
  publication-title: Science
  doi: 10.1126/science.aav0173
– volume: 10
  start-page: 387
  year: 2021
  end-page: 407
  ident: CR119
  article-title: Key activating and inhibitory ligands involved in the mobilization of natural killer cells for cancer immunotherapies
  publication-title: Immunotargets Ther.
  doi: 10.2147/ITT.S306109
– volume: 78
  start-page: 4803
  year: 2018
  end-page: 8
  ident: CR68
  article-title: The effects of cholesterol-derived oncometabolites on nuclear receptor function in cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-1487
– volume: 116
  start-page: 105610
  year: 2019
  ident: CR140
  article-title: Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2019.105610
– volume: 80
  start-page: 1748
  year: 2020
  end-page: 61
  ident: CR20
  article-title: Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-1999
– volume: 80
  start-page: 2874
  year: 2020
  end-page: 88
  ident: CR84
  article-title: Tumor-derived prostaglandin E2 Promotes p50 NF-κB-dependent differentiation of monocytic MDSCs
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-2843
– volume: 17
  start-page: 2318
  year: 2019
  end-page: 30
  ident: CR147
  article-title: Targeting the Mevalonate pathway to overcome acquired Anti-HER2 treatment resistance in breast cancer
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-19-0756
– volume: 165
  start-page: 100
  year: 2016
  end-page: 10
  ident: CR112
  article-title: Cytotoxic T cells use mechanical force to potentiate target cell killing
  publication-title: Cell
  doi: 10.1016/j.cell.2016.01.021
– volume: 68
  start-page: 5246
  year: 2008
  end-page: 56
  ident: CR145
  article-title: Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6161
– volume: 30
  start-page: 108
  year: 2016
  end-page: 19
  ident: CR151
  article-title: Oncolytic virus-mediated targeting of PGE2 in the tumor alters the immune status and sensitizes established and resistant tumors to immunotherapy
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.05.012
– volume: 8
  start-page: e2593
  year: 2017
  ident: CR77
  article-title: Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.21
– volume: 39
  start-page: e102525
  year: 2020
  ident: CR80
  article-title: Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells
  publication-title: EMBO J
  doi: 10.15252/embj.2019102525
– volume: 129
  start-page: 3594
  year: 2019
  end-page: 609
  ident: CR113
  article-title: Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2)
  publication-title: J Clin Invest
  doi: 10.1172/JCI127755
– volume: 16
  start-page: 732
  year: 2016
  end-page: 49
  ident: CR31
  article-title: The multifaceted roles of fatty acid synthesis in cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2016.89
– volume: 80
  start-page: 101055
  year: 2020
  ident: CR9
  article-title: Lipids in the tumor microenvironment: from cancer progression to treatment
  publication-title: Prog Lipid Res
  doi: 10.1016/j.plipres.2020.101055
– volume: 528
  start-page: 413
  year: 2015
  end-page: 7
  ident: CR44
  article-title: Neutrophils support lung colonization of metastasis-initiating breast cancer cells
  publication-title: Nature
  doi: 10.1038/nature16140
– volume: 172
  start-page: 1022
  year: 2018
  end-page: .e14
  ident: CR121
  article-title: NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control
  publication-title: Cell
  doi: 10.1016/j.cell.2018.01.004
– volume: 111
  start-page: 151
  year: 2017
  end-page: 5
  ident: CR67
  article-title: Cholesterol and related sterols autoxidation
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2017.04.013
– volume: 3
  start-page: 96
  year: 2013
  end-page: 111
  ident: CR148
  article-title: Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-12-0031
– volume: 21
  start-page: 753
  year: 2021
  end-page: 66
  ident: CR12
  article-title: Tumour fatty acid metabolism in the context of therapy resistance and obesity
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-021-00388-4
– volume: 484
  start-page: 857
  year: 2017
  end-page: 63
  ident: CR71
  article-title: 25-Hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells
  publication-title: Biochemical Biophysical Res Commun
  doi: 10.1016/j.bbrc.2017.02.003
– volume: 517
  start-page: 209
  year: 2015
  end-page: 13
  ident: CR141
  article-title: Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
  publication-title: Nature
  doi: 10.1038/nature14034
– volume: 122
  start-page: 4
  year: 2020
  end-page: 22
  ident: CR4
  article-title: Reprogramming of fatty acid metabolism in cancer
  publication-title: Br J Cancer
  doi: 10.1038/s41416-019-0650-z
– volume: 29
  start-page: 1376
  year: 2019
  end-page: .e4
  ident: CR93
  article-title: Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.02.016
– volume: 32
  start-page: 81
  year: 2011
  end-page: 151
  ident: CR49
  article-title: The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders
  publication-title: Endocr Rev
  doi: 10.1210/er.2010-0013
– volume: 2
  start-page: 414
  year: 2021
  end-page: 28
  ident: CR37
  article-title: Fatty acid synthesis is required for breast cancer brain metastasis
  publication-title: Nat Cancer
  doi: 10.1038/s43018-021-00183-y
– volume: 30
  start-page: 36
  year: 2019
  end-page: 50
  ident: CR88
  article-title: Macrophages and metabolism in the tumor microenvironment
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.06.001
– volume: 37
  start-page: 2285
  year: 2018
  end-page: 301
  ident: CR21
  article-title: Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
  publication-title: Oncogene
  doi: 10.1038/s41388-017-0093-z
– volume: 33
  start-page: 1001
  year: 2021
  end-page: .e5
  ident: CR115
  article-title: CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2021.02.015
– volume: 16
  start-page: 98
  year: 2010
  end-page: 105
  ident: CR102
  article-title: Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
  publication-title: Nat Med
  doi: 10.1038/nm.2074
– volume: 67
  start-page: 979
  year: 2017
  end-page: 90
  ident: CR135
  article-title: Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.06.015
– volume: 40
  start-page: 290
  year: 2019
  end-page: 304
  ident: CR138
  article-title: PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2018.11.045
– volume: 77
  start-page: 5503
  year: 2017
  end-page: 17
  ident: CR133
  article-title: De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-3062
– volume: 76
  start-page: 2037
  year: 2016
  end-page: 49
  ident: CR55
  article-title: Candidate antimetastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-1970
– volume: 64
  start-page: 152
  year: 2016
  end-page: 69
  ident: CR51
  article-title: Oxysterols: from cholesterol metabolites to key mediators
  publication-title: Prog Lipid Res
  doi: 10.1016/j.plipres.2016.09.002
– volume: 591
  start-page: 306
  year: 2021
  end-page: 11
  ident: CR100
  article-title: Lipid signalling enforces functional specialization of Treg cells in tumours
  publication-title: Nature
  doi: 10.1038/s41586-021-03235-6
– volume: 481
  start-page: 380
  year: 2011
  end-page: 4
  ident: CR33
  article-title: Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
  publication-title: Nature
  doi: 10.1038/nature10602
– volume: 236
  start-page: 5253
  year: 2021
  end-page: 264
  ident: CR59
  article-title: LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.30229
– volume: 1868
  start-page: 1
  year: 2017
  end-page: 6
  ident: CR125
  article-title: Linking metabolic reprogramming to therapy resistance in cancer
  publication-title: Biochim Biophys Acta Rev Cancer
  doi: 10.1016/j.bbcan.2016.12.004
– volume: 9
  start-page: 112
  year: 2008
  end-page: 24
  ident: CR2
  article-title: Membrane lipids: where they are and how they behave
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2330
– volume: 5
  start-page: 693
  year: 2019
  end-page: 703
  ident: CR5
  article-title: Lipid metabolism at the nexus of diet and tumor microenvironment
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2019.09.007
– volume: 499
  start-page: 485
  year: 2013
  end-page: 90
  ident: CR97
  article-title: mTORC1 couples immune signals and metabolic programming to establish T reg -cell function
  publication-title: Nature
  doi: 10.1038/nature12297
– volume: 10
  start-page: 181
  year: 2010
  end-page: 93
  ident: CR39
  article-title: Eicosanoids and cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2809
– volume: 7
  start-page: 682
  year: 2021
  end-page: 99
  ident: CR124
  article-title: Metabolic reprogramming in anticancer drug resistance: a focus on amino acids
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2021.02.004
– volume: 144
  start-page: 178
  year: 2019
  end-page: 89
  ident: CR137
  article-title: Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31868
– volume: 200
  start-page: 1839
  year: 2018
  end-page: 52
  ident: CR45
  article-title: Alveolar macrophages drive hepatocellular carcinoma lung metastasis by generating leukotriene B4
  publication-title: J Immunol
– volume: 403
  start-page: 260
  year: 2017
  end-page: 70
  ident: CR40
  article-title: cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial–mesenchymal transition of hepatocellular carcinoma cells
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.06.022
– volume: 23
  start-page: e87489.
  year: 2017
  ident: CR78
  article-title: Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells
  publication-title: JCI Insight
– volume: 20
  start-page: 174
  year: 2020
  end-page: 86
  ident: CR76
  article-title: A framework for advancing our understanding of cancer-associated fibroblasts
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-019-0238-1
– volume: 5
  year: 2015
  ident: CR23
  article-title: Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
  publication-title: Sci Rep
  doi: 10.1038/srep14752
– volume: 158
  start-page: 971
  year: 2020
  end-page: .e10
  ident: CR41
  article-title: Prostaglandin E2 induces miR675-5p to promote colorectal tumor metastasis via modulation of p53 expression
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.11.013
– volume: 5
  year: 2015
  ident: CR60
  article-title: The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
  publication-title: Sci Rep
  doi: 10.1038/srep09054
– volume: 6
  start-page: e1344804
  year: 2017
  ident: CR87
  article-title: Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
  publication-title: OncoImmunology
  doi: 10.1080/2162402X.2017.1344804
– volume: 569
  start-page: 73
  year: 2019
  end-page: 78
  ident: CR110
  article-title: Fatty acid transport protein 2 reprograms neutrophils in cancer
  publication-title: Nature
  doi: 10.1038/s41586-019-1118-2
– volume: 48
  start-page: 147
  year: 2018
  end-page: .e7
  ident: CR149
  article-title: Paracrine Wnt5a-β-catenin signaling triggers a metabolic program that drives dendritic cell tolerization
  publication-title: Immunity
  doi: 10.1016/j.immuni.2017.12.004
– volume: 8
  start-page: 1124
  year: 2017
  ident: CR120
  article-title: The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.01124
– volume: 9
  start-page: 2927
  year: 2018
  ident: CR103
  article-title: Ovarian cancer-intrinsic fatty acid synthase prevents anti-tumor immunity by disrupting tumor-infiltrating dendritic cells
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02927
– volume: 473
  start-page: 74
  year: 2020
  end-page: 89
  ident: CR130
  article-title: Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2019.12.036
– volume: 76
  start-page: 220
  year: 2019
  end-page: 31
  ident: CR8
  article-title: Even cancer cells watch their cholesterol!
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2019.09.008
– volume: 425
  start-page: 13
  year: 2018
  end-page: 20
  ident: CR54
  article-title: Squalene epoxidase as a promising metabolic target in cancer treatment
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2018.03.034
– volume: 115
  start-page: E6546
  year: 2018
  end-page: E6555.
  ident: CR99
  article-title: Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1720113115
– volume: 79
  start-page: 3063
  year: 2019
  end-page: 75
  ident: CR58
  article-title: Cholesterol induces epithelial-to-mesenchymal transition of prostate cancer cells by suppressing degradation of EGFR through APMAP
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3295
– volume: 182
  start-page: 4499
  year: 2009
  end-page: 506
  ident: CR83
  article-title: Myeloid-derived suppressor cells: linking inflammation and cancer
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0802740
– volume: 38
  start-page: 2076
  year: 2019
  end-page: 91
  ident: CR57
  article-title: CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0570-z
– volume: 10
  start-page: 1797
  year: 2020
  end-page: 807
  ident: CR3
  article-title: Targeting metabolic plasticity and flexibility dynamics for cancer therapy
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-20-0844
– volume: 69
  start-page: 480
  year: 2018
  end-page: .e7
  ident: CR24
  article-title: Nuclear receptor Nur77 facilitates melanoma cell survival under metabolic stress by protecting fatty acid oxidation
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2018.01.001
– volume: 42
  start-page: 1010428320941760
  year: 2020
  ident: CR52
  article-title: Attempts to use statins in cancer therapy: an update
  publication-title: Tumour Biol
  doi: 10.1177/1010428320941760
– volume: 297
  start-page: E1
  year: 2009
  end-page: E9.
  ident: CR62
  article-title: Acyl-coenzyme A: cholesterol acyltransferases
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.90926.2008
– volume: 38
  start-page: 567
  year: 2020
  end-page: 583.e11
  ident: CR61
  article-title: Cholesterol pathway inhibition induces TGF-β signaling to promote basal differentiation in pancreatic cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.08.015
– volume: 15
  start-page: 73
  year: 2015
  end-page: 86
  ident: CR82
  article-title: Immune cell promotion of metastasis
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3789
– volume: 5
  start-page: 695
  year: 2017
  end-page: 709
  ident: CR150
  article-title: Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-16-0400
– volume: 9
  start-page: 2
  year: 2021
  ident: CR7
  article-title: The diversity and breadth of cancer cell fatty acid metabolism
  publication-title: Cancer Metab
  doi: 10.1186/s40170-020-00237-2
– volume: 588
  start-page: 331
  year: 2020
  end-page: 6
  ident: CR36
  article-title: A metastasis map of human cancer cell lines
  publication-title: Nature
  doi: 10.1038/s41586-020-2969-2
– volume: 8
  start-page: e2728
  year: 2017
  end-page: e2728
  ident: CR42
  article-title: cPLA2α mediates TGF-β-induced epithelial–mesenchymal transition in breast cancer through PI3k/Akt signaling
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.152
– volume: 541
  start-page: 41
  year: 2017
  end-page: 5
  ident: CR22
  article-title: Targeting metastasis-initiating cells through the fatty acid receptor CD36
  publication-title: Nature
  doi: 10.1038/nature20791
– volume: 9
  start-page: 125
  year: 2008
  end-page: 38
  ident: CR48
  article-title: Cellular cholesterol trafficking and compartmentalization
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2336
– volume: 143
  start-page: 992
  year: 2018
  end-page: 1002
  ident: CR131
  article-title: The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31392
– volume: 158
  start-page: 477
  year: 2016
  end-page: 89
  ident: CR47
  article-title: Lipid osteoclastokines regulate breast cancer bone metastasis
  publication-title: Endocrinology
  doi: 10.1210/en.2016-1570
– volume: 5
  year: 2015
  ident: 420_CR23
  publication-title: Sci Rep
  doi: 10.1038/srep14752
– volume: 16
  start-page: 974
  year: 2018
  ident: 420_CR63
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-17-0665
– volume: 31
  start-page: 62
  year: 2020
  ident: 420_CR13
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.11.010
– volume: 162
  start-page: 1257
  year: 2015
  ident: 420_CR85
  publication-title: Cell
  doi: 10.1016/j.cell.2015.08.015
– volume: 67
  start-page: 979
  year: 2017
  ident: 420_CR135
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.06.015
– volume: 5
  start-page: 693
  year: 2019
  ident: 420_CR5
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2019.09.007
– volume: 39
  start-page: 3179
  year: 2020
  ident: 420_CR43
  publication-title: Oncogene
  doi: 10.1038/s41388-020-1207-6
– volume: 210
  start-page: 1711
  year: 2013
  ident: 420_CR107
  publication-title: J Exp Med
  doi: 10.1084/jem.20130440
– volume: 11
  start-page: 591819.
  year: 2020
  ident: 420_CR66
  publication-title: Front Endocrinol
  doi: 10.3389/fendo.2020.591819
– volume: 17
  start-page: 1498
  year: 2011
  ident: 420_CR18
  publication-title: Nat Med
  doi: 10.1038/nm.2492
– volume: 30
  start-page: 143
  year: 2019
  ident: 420_CR114
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.04.002
– volume: 80
  start-page: 4932
  year: 2020
  ident: 420_CR29
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-20-1255
– volume: 16
  start-page: 98
  year: 2010
  ident: 420_CR102
  publication-title: Nat Med
  doi: 10.1038/nm.2074
– volume: 19
  start-page: 393
  year: 2014
  ident: 420_CR65
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2014.01.019
– volume: 39
  start-page: 6139
  year: 2020
  ident: 420_CR17
  publication-title: Oncogene
  doi: 10.1038/s41388-020-01432-7
– volume: 69
  start-page: 480
  year: 2018
  ident: 420_CR24
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2018.01.001
– volume: 363
  start-page: 644
  year: 2019
  ident: 420_CR25
  publication-title: Science
  doi: 10.1126/science.aav0173
– volume: 67
  start-page: 7450
  year: 2007
  ident: 420_CR152
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-0199
– volume: 9
  start-page: 617
  year: 2019
  ident: 420_CR10
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-18-1212
– volume: 8
  year: 2017
  ident: 420_CR105
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-02186-9
– volume: 9
  year: 2018
  ident: 420_CR19
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-04987-y
– volume: 3
  start-page: 1236
  year: 2015
  ident: 420_CR86
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-15-0036
– volume: 50
  start-page: 100682
  year: 2020
  ident: 420_CR122
  publication-title: Drug Resist Updates
  doi: 10.1016/j.drup.2020.100682
– volume: 34
  start-page: 1241
  year: 2015
  ident: 420_CR91
  publication-title: Oncogene
  doi: 10.1038/onc.2014.85
– volume: 76
  start-page: 220
  year: 2019
  ident: 420_CR8
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2019.09.008
– volume: 129
  start-page: 3594
  year: 2019
  ident: 420_CR113
  publication-title: J Clin Invest
  doi: 10.1172/JCI127755
– volume: 33
  start-page: 1001
  year: 2021
  ident: 420_CR115
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2021.02.015
– volume: 15
  start-page: 73
  year: 2015
  ident: 420_CR82
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3789
– volume: 32
  start-page: 81
  year: 2011
  ident: 420_CR49
  publication-title: Endocr Rev
  doi: 10.1210/er.2010-0013
– volume: 3
  start-page: 96
  year: 2013
  ident: 420_CR148
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-12-0031
– volume: 71
  start-page: 6400
  year: 2011
  ident: 420_CR95
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-1261
– volume: 5
  start-page: 28
  year: 2020
  ident: 420_CR15
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-0134-x
– volume: 161
  start-page: 290
  year: 2010
  ident: 420_CR153
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2010.04167.x
– volume: 172
  start-page: 1022
  year: 2018
  ident: 420_CR121
  publication-title: Cell
  doi: 10.1016/j.cell.2018.01.004
– volume: 12
  start-page: 795159.
  year: 2022
  ident: 420_CR89
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.795159
– volume: 114
  start-page: 1117
  year: 2017
  ident: 420_CR94
  publication-title: PNAS
  doi: 10.1073/pnas.1612920114
– volume: 8
  start-page: 1124
  year: 2017
  ident: 420_CR120
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.01124
– volume: 8
  year: 2017
  ident: 420_CR69
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-00910-z
– volume: 8
  start-page: e2593
  year: 2017
  ident: 420_CR77
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.21
– volume: 112
  start-page: 2473
  year: 2015
  ident: 420_CR143
  publication-title: PNAS
  doi: 10.1073/pnas.1421601112
– volume: 20
  start-page: 137
  year: 2019
  ident: 420_CR26
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-018-0085-z
– volume: 165
  start-page: 100
  year: 2016
  ident: 420_CR112
  publication-title: Cell
  doi: 10.1016/j.cell.2016.01.021
– volume: 9
  start-page: 2
  year: 2021
  ident: 420_CR7
  publication-title: Cancer Metab
  doi: 10.1186/s40170-020-00237-2
– volume: 21
  start-page: 753
  year: 2021
  ident: 420_CR12
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-021-00388-4
– volume: 588
  start-page: 331
  year: 2020
  ident: 420_CR36
  publication-title: Nature
  doi: 10.1038/s41586-020-2969-2
– volume: 9
  year: 2018
  ident: 420_CR136
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-02732-5
– volume: 50
  start-page: 206
  year: 2018
  ident: 420_CR38
  publication-title: Nat Genet
  doi: 10.1038/s41588-017-0027-2
– volume: 79
  start-page: 1165
  year: 2019
  ident: 420_CR142
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-0921
– volume: 79
  start-page: 3063
  year: 2019
  ident: 420_CR58
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3295
– volume: 13
  start-page: e0193318
  year: 2018
  ident: 420_CR144
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0193318
– volume: 8
  start-page: e79633
  year: 2013
  ident: 420_CR111
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0079633
– volume: 473
  start-page: 74
  year: 2020
  ident: 420_CR130
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2019.12.036
– volume: 8
  start-page: 5574
  year: 2019
  ident: 420_CR14
  publication-title: Cancer Med
  doi: 10.1002/cam4.2474
– volume: 541
  start-page: 41
  year: 2017
  ident: 420_CR22
  publication-title: Nature
  doi: 10.1038/nature20791
– volume: 143
  start-page: 992
  year: 2018
  ident: 420_CR131
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31392
– volume: 42
  start-page: 101042832094176
  year: 2020
  ident: 420_CR52
  publication-title: Tumour Biol
  doi: 10.1177/1010428320941760
– volume: 10
  start-page: 648
  year: 2020
  ident: 420_CR74
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-19-1353
– volume: 30
  start-page: 36
  year: 2019
  ident: 420_CR88
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.06.001
– volume: 9
  start-page: 112
  year: 2008
  ident: 420_CR2
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2330
– volume: 9
  start-page: 125
  year: 2008
  ident: 420_CR48
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2336
– volume: 3
  start-page: 344
  year: 2012
  ident: 420_CR75
  publication-title: Front Physiol
  doi: 10.3389/fphys.2012.00344
– volume: 35
  start-page: 6378
  year: 2016
  ident: 420_CR64
  publication-title: Oncogene
  doi: 10.1038/onc.2016.168
– volume: 122
  start-page: 4
  year: 2020
  ident: 420_CR4
  publication-title: Br J Cancer
  doi: 10.1038/s41416-019-0650-z
– volume: 140
  start-page: 49
  year: 2010
  ident: 420_CR28
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.027
– volume: 68
  start-page: 5246
  year: 2008
  ident: 420_CR145
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6161
– volume: 10
  start-page: 836.
  year: 2019
  ident: 420_CR139
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2019.00836
– volume: 531
  start-page: 651
  year: 2016
  ident: 420_CR118
  publication-title: Nature
  doi: 10.1038/nature17412
– volume: 3
  start-page: 1445
  year: 2021
  ident: 420_CR27
  publication-title: Nat Metab
  doi: 10.1038/s42255-021-00493-6
– volume: 8
  start-page: e2728
  year: 2017
  ident: 420_CR42
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.152
– volume: 27
  start-page: 57
  year: 2015
  ident: 420_CR32
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2014.12.002
– volume: 10
  start-page: 1510.10.
  year: 2020
  ident: 420_CR53
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.01510
– volume: 80
  start-page: 101055
  year: 2020
  ident: 420_CR9
  publication-title: Prog Lipid Res
  doi: 10.1016/j.plipres.2020.101055
– volume: 2
  start-page: 414
  year: 2021
  ident: 420_CR37
  publication-title: Nat Cancer
  doi: 10.1038/s43018-021-00183-y
– volume: 2
  start-page: 141
  year: 2019
  ident: 420_CR123
  publication-title: Cancer Drug Resist
– volume: 158
  start-page: 971
  year: 2020
  ident: 420_CR41
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.11.013
– volume: 21
  start-page: 283
  year: 2022
  ident: 420_CR34
  publication-title: Nat Rev Drug Disco
  doi: 10.1038/s41573-021-00367-2
– volume: 54
  start-page: 1561
  year: 2021
  ident: 420_CR116
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.05.003
– volume: 39
  start-page: e102525
  year: 2020
  ident: 420_CR80
  publication-title: EMBO J
  doi: 10.15252/embj.2019102525
– volume: 115
  start-page: E6546
  year: 2018
  ident: 420_CR99
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1720113115
– volume: 38
  start-page: 567
  year: 2020
  ident: 420_CR61
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.08.015
– volume: 10
  start-page: 181
  year: 2010
  ident: 420_CR39
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2809
– volume: 528
  start-page: 413
  year: 2015
  ident: 420_CR44
  publication-title: Nature
  doi: 10.1038/nature16140
– volume: 21
  start-page: 1444
  year: 2020
  ident: 420_CR46
  publication-title: Nat Immunol
  doi: 10.1038/s41590-020-0783-5
– volume: 5
  start-page: 695
  year: 2017
  ident: 420_CR150
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-16-0400
– volume: 78
  start-page: 4803
  year: 2018
  ident: 420_CR68
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-1487
– volume: 76
  start-page: 2037
  year: 2016
  ident: 420_CR55
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-1970
– volume: 591
  start-page: 306
  year: 2021
  ident: 420_CR100
  publication-title: Nature
  doi: 10.1038/s41586-021-03235-6
– volume: 16
  start-page: 880
  year: 2010
  ident: 420_CR104
  publication-title: Nat Med
  doi: 10.1038/nm.2172
– volume: 70
  start-page: 8117
  year: 2010
  ident: 420_CR132
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3871
– volume: 11
  year: 2020
  ident: 420_CR101
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-17339-6
– volume: 3
  start-page: 034002
  year: 2017
  ident: 420_CR81
  publication-title: Converg Sci Phys Oncol
  doi: 10.1088/2057-1739/aa7e86
– volume: 6
  start-page: 593
  year: 2020
  ident: 420_CR11
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2020.03.001
– volume: 17
  start-page: 2318
  year: 2019
  ident: 420_CR147
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-19-0756
– volume: 81
  start-page: 4305
  year: 2021
  ident: 420_CR92
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-20-3929
– volume: 481
  start-page: 380
  year: 2011
  ident: 420_CR33
  publication-title: Nature
  doi: 10.1038/nature10602
– volume: 484
  start-page: 857
  year: 2017
  ident: 420_CR71
  publication-title: Biochemical Biophysical Res Commun
  doi: 10.1016/j.bbrc.2017.02.003
– volume: 499
  start-page: 485
  year: 2013
  ident: 420_CR97
  publication-title: Nature
  doi: 10.1038/nature12297
– volume: 429
  start-page: 66
  year: 2018
  ident: 420_CR56
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2018.04.038
– volume: 1868
  start-page: 1
  year: 2017
  ident: 420_CR125
  publication-title: Biochim Biophys Acta Rev Cancer
  doi: 10.1016/j.bbcan.2016.12.004
– volume: 28
  start-page: 408
  year: 2017
  ident: 420_CR1
  publication-title: Curr Opin Lipido
  doi: 10.1097/MOL.0000000000000443
– volume: 3
  start-page: 1191
  year: 2013
  ident: 420_CR50
  publication-title: Compr Physiol
  doi: 10.1002/cphy.c120023
– volume: 20
  start-page: 174
  year: 2020
  ident: 420_CR76
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-019-0238-1
– volume: 40
  start-page: 290
  year: 2019
  ident: 420_CR138
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2018.11.045
– volume: 1861
  start-page: 148300
  year: 2020
  ident: 420_CR129
  publication-title: Biochim Biophys Acta Bioenerg
  doi: 10.1016/j.bbabio.2020.148300
– volume: 6
  start-page: e1344804
  year: 2017
  ident: 420_CR87
  publication-title: OncoImmunology
  doi: 10.1080/2162402X.2017.1344804
– volume: 29
  start-page: 3405
  year: 2019
  ident: 420_CR126
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2019.11.008
– volume: 5
  year: 2015
  ident: 420_CR60
  publication-title: Sci Rep
  doi: 10.1038/srep09054
– volume: 18
  start-page: 3337
  year: 2019
  ident: 420_CR146
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2019.1676581
– volume: 54
  start-page: 966
  year: 2019
  ident: 420_CR70
  publication-title: Int J Oncol
– volume: 16
  start-page: 732
  year: 2016
  ident: 420_CR31
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2016.89
– volume: 403
  start-page: 260
  year: 2017
  ident: 420_CR40
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.06.022
– volume: 144
  start-page: 178
  year: 2019
  ident: 420_CR137
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31868
– volume: 21
  start-page: 298
  year: 2020
  ident: 420_CR98
  publication-title: Nat Immunol
  doi: 10.1038/s41590-019-0589-5
– volume: 120
  start-page: 45
  year: 2019
  ident: 420_CR73
  publication-title: Br J Cancer
  doi: 10.1038/s41416-018-0327-z
– volume: 7
  start-page: 716
  year: 2017
  ident: 420_CR128
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-16-0441
– volume: 32
  start-page: 377
  year: 2017
  ident: 420_CR117
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.08.004
– volume: 10
  start-page: 1797
  year: 2020
  ident: 420_CR3
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-20-0844
– volume: 23
  start-page: e87489.
  year: 2017
  ident: 420_CR78
  publication-title: JCI Insight
– volume: 517
  start-page: 209
  year: 2015
  ident: 420_CR141
  publication-title: Nature
  doi: 10.1038/nature14034
– volume: 25
  start-page: E3935
  year: 2020
  ident: 420_CR35
  publication-title: Molecules
  doi: 10.3390/molecules25173935
– volume: 114
  start-page: E6556
  year: 2017
  ident: 420_CR30
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1703791114
– volume: 111
  start-page: 151
  year: 2017
  ident: 420_CR67
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2017.04.013
– volume: 64
  start-page: 152
  year: 2016
  ident: 420_CR51
  publication-title: Prog Lipid Res
  doi: 10.1016/j.plipres.2016.09.002
– volume: 76
  start-page: 4051
  year: 2016
  ident: 420_CR79
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-0651
– volume: 236
  start-page: 5253
  year: 2021
  ident: 420_CR59
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.30229
– volume: 25
  start-page: 6852
  year: 2019
  ident: 420_CR127
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-19-0253
– volume: 182
  start-page: 4499
  year: 2009
  ident: 420_CR83
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0802740
– volume: 297
  start-page: E1
  year: 2009
  ident: 420_CR62
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.90926.2008
– volume: 51
  start-page: 381
  year: 2019
  ident: 420_CR96
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.06.017
– volume: 132
  start-page: e148550.132.
  year: 2022
  ident: 420_CR134
  publication-title: J Clin Invest
  doi: 10.1172/JCI148550
– volume: 569
  start-page: 73
  year: 2019
  ident: 420_CR110
  publication-title: Nature
  doi: 10.1038/s41586-019-1118-2
– volume: 9
  start-page: 2927
  year: 2018
  ident: 420_CR103
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02927
– volume: 64
  start-page: 1476
  year: 2015
  ident: 420_CR72
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-309304
– volume: 38
  start-page: 2076
  year: 2019
  ident: 420_CR57
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0570-z
– volume: 21
  start-page: 162
  year: 2021
  ident: 420_CR16
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-020-00320-2
– volume: 7
  start-page: 682
  year: 2021
  ident: 420_CR124
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2021.02.004
– volume: 158
  start-page: 477
  year: 2016
  ident: 420_CR47
  publication-title: Endocrinology
  doi: 10.1210/en.2016-1570
– volume: 29
  start-page: 1376
  year: 2019
  ident: 420_CR93
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.02.016
– volume: 77
  start-page: 5503
  year: 2017
  ident: 420_CR133
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-3062
– volume: 80
  start-page: 1748
  year: 2020
  ident: 420_CR20
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-1999
– volume: 425
  start-page: 13
  year: 2018
  ident: 420_CR54
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2018.03.034
– volume: 113
  start-page: E6219
  year: 2016
  ident: 420_CR108
  publication-title: PNAS
  doi: 10.1073/pnas.1613332113
– volume: 200
  start-page: 1839
  year: 2018
  ident: 420_CR45
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1700544
– volume: 6
  year: 2015
  ident: 420_CR109
  publication-title: Nat Commun
  doi: 10.1038/ncomms8064
– volume: 10
  start-page: 387
  year: 2021
  ident: 420_CR119
  publication-title: Immunotargets Ther.
  doi: 10.2147/ITT.S306109
– volume: 159
  start-page: 245
  year: 2020
  ident: 420_CR6
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2020.07.013
– volume: 13
  start-page: 453
  year: 2008
  ident: 420_CR90
  publication-title: Front Biosci
  doi: 10.2741/2692
– volume: 80
  start-page: 2874
  year: 2020
  ident: 420_CR84
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-2843
– volume: 48
  start-page: 147
  year: 2018
  ident: 420_CR149
  publication-title: Immunity
  doi: 10.1016/j.immuni.2017.12.004
– volume: 37
  start-page: 2285
  year: 2018
  ident: 420_CR21
  publication-title: Oncogene
  doi: 10.1038/s41388-017-0093-z
– volume: 10
  start-page: 581457.
  year: 2020
  ident: 420_CR106
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.581457
– volume: 116
  start-page: 105610
  year: 2019
  ident: 420_CR140
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2019.105610
– volume: 30
  start-page: 108
  year: 2016
  ident: 420_CR151
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.05.012
SSID ssj0000561655
Score 2.5644863
SecondaryResourceType review_article
Snippet Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor...
Abstract Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor...
SourceID doaj
pubmedcentral
hal
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 46
SubjectTerms 13
38
631/67/2327
631/67/327
64
64/110
96
Adipocytes
Antibodies
Apoptosis
Cancer
Cell activation
Cell Biology
Cholesterol
Fatty acids
Fibroblasts
Glycerol
Human Genetics
Immunotherapy
Internal Medicine
Life Sciences
Lipids
Medicine
Medicine & Public Health
Metabolism
Metabolites
Metastases
Metastasis
Oncology
Oxidation
Review
Review Article
Treatment resistance
Tumor microenvironment
Tumors
SummonAdditionalLinks – databaseName: Science Database (subscription)
  dbid: M2P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagIMSFNyJQkEHcwKpjO7HDBRVE1QOteuihN8uv0JXapGzSRfx7PI43ZSvRC1fbsZPM2PPZM_4GofeyjXa0cpRQySyJq2RFrPANYV4wRgMwlJuUbEIeHqqTk-YoH7gNOaxyvSamhdr3Ds7Id5KDVMbdhfp88ZNA1ijwruYUGrfRnYhsSgjpOmBH8xkLoOO6qvJdGcrVziDAMUcghB3UlRK1YY8SbX-0MqcQFPkX4rweL3nNaZps0d7D__2KR-hBRqF4d1Kbx-hW6J6gewfZz_4UrSCltR_wosMO1GL5CRs8cYdgGAH3LY7IEadA95wxC8rO4DEMWY5_md8DHnt8HkYDl5YWDs_3JLHpPJ4j3HHc8AOIjcM8Q8d7346_7pOcoYG4iLRGIg3YN-XSzoiHsnaV91WI25ySWUE9o6YJLijJRUVZW1sX_2FouLWhrauWP0dbXd-FFwhXitc-SGsa4MdntQ0-gifPYl-2CaoqULkWk3aZvRySaJzp5EXnSk-i1VG0OolWqwJ9mJ-5mLg7bmz9BaQ_twTe7VTQL3_oPI21DNxHSCYBqAkjhFWAIY2JsEcGakWB3kXd2ehjf_e7hjLKmxruKa_KAm2vlUPnFWPQV5pRoLdzdZzr4MAxXegvpza1ANLEAskNldwYcbOmW5wm1vCGx1euaYE-rpX3avB__5WXN7_rK3SfpckEMTTbaGtcXobX6K5bjYth-SbNxj8F9jrz
  priority: 102
  providerName: ProQuest
Title Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance
URI https://link.springer.com/article/10.1038/s41389-022-00420-8
https://www.proquest.com/docview/2700171918
https://www.proquest.com/docview/2700640454
https://amu.hal.science/hal-03962099
https://pubmed.ncbi.nlm.nih.gov/PMC9363460
https://doaj.org/article/7e3d102706634a44b80250aa8187e0b4
Volume 11
WOSCitedRecordID wos000838082400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2157-9024
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000561655
  issn: 2157-9024
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2157-9024
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000561655
  issn: 2157-9024
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagIMQF8RSBsjKIG0R1nMR2uLVoqyKxqwj1sJwsO_aqK7VZtEkXceG3M-Nkw6YScOHigx-xNTPOzGjG3xDyVi5Bj-YVi5nkNoa_ZB7bzBUxdxnnzCNCuQnFJuR8rhaLotwr9YU5YR08cEe4I-lTB0pQomrMTJZZhVrbGFA00jMbkECZLPacqQ7VWyQiz_tXMixVR02GIbkYk9dRUFmsRpooAPaDfrnAdMg9W_NmpuSNcGnQQqcPyYPefKTH3bEfkVu-fkzuzfoA-ROyxVrUrqGrmlbIz80HamgH-kExCEDXSwomHw0Z6n2pK-y7xGUUyxN_Nz8a2q7plW8NvjZaVXR44EhN7eiQmk7BU0frE7Z5Ss5Pp-cfz-K-tEJcgYnUxtKgYlJVcGlSn4gqdy734J8k3GbMcWYKX3kl0yxnfClsBSTwRWqtX4p8mT4jB_W69s8JzVUqnJfWFAhsz4X1Dqwex-FbtvAqj0iyo7KuethxrH5xqUP4O1W644wGzujAGa0i8m5Y860D3fjr7BNk3jATAbNDB4iR7sVI_0uMIvIGWD_6xtnxZ419LC0EPjDeJhE53EmG7q96o0PkXoLbCwd5PQzDJcXIi6n9-rqbIzJEO4yIHEnUaMfxSL26CHDfRQpHFiwi73ey93vzP1Plxf-gyktyn4cbgykyh-Sg3Vz7V-RutW1XzWZCbsuFDK2akDsn03n5ZRKuIbQzXmIrQ_tzCuPlp1n59Rf53DOd
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoALb0SggEFwolGzjhM7SAiVR7VVt6se9tCb5dfSlUpSNtut-qP4j3icR9lK9NYDV8ex85jHl8w3MwDv-NT70cwkccKpjr2VzGLNbBFTyyhNHFYoV6HZBB-PxeFhcbAGv7tcGKRVdjYxGGpbGfxHvhUCpNx_XYjPJ79i7BqF0dWuhUYjFnvu_Mx_stWfdr_59_ue0p3vk6_DuO0qEBuPDhYxV2iThQloPnWD3GTWZs5D8wHVLLE0UYUzTvCUZQmd5tpY70iKVGs3zbNp6pe9ATcZFhZDpiA96H_pIBjPs6xNzUlSsVUzjAPGyJhH7UhiseL-QpcA79SOkIP5F8C9TM-8FKMNrm_n_n_20B7AvRZjk-1GKR7Cmisfwe39lkXwGJbYsNvWZFYSg0I__0gUaSqjELwhUk2Jx8Uk0PjbfmA4doynEezhfKbOa7KoyE-3UJiSNTOkzwIlqrSk5--TuasRovttnsDkOm76KayXVemeAclEmlvHtSqw-j_NtbMeGlrq19KFE1kEg04qpGlrs2OLkGMZOAKpkI0kSS9JMkiSFBF86M85aSqTXDn7CwpbPxOrioeBav5DtkZKcpdaDzg5wlCmGNMCEbJSHtRxl2gWwVsvqitrDLdHEseStMgxC3s5iGCjk0XZ2sNaXghiBG_6w96SYXhKla46bebkDEtCRsBXNGBlx9Uj5ewo1EQvUn_JeRLBZqcrF5v_-6k8v_paX8Od4WR_JEe7470XcJcGPUa20AasL-an7iXcMsvFrJ6_CoaAgLxmHfoDL3-XSA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLaq48EYEChgEJ4g26zixg4RQoay6arvaQw_lZNmxQ1cqSdlsW_Wn8e_wOI-yleitB66OY-cxjy-Zb2YA3vLC-dEkj8KIUx06K5mEmpkspIZRGlmsUK58swk-nYrDw2y2Br-7XBikVXY20RtqU-X4j3zoA6TcfV2IYdHSImbb488nv0LsIIWR1q6dRiMiu_bi3H2-1Z8m2-5dv6N0_O3g607YdhgIc4cUliFXaJ9F7pF9bEdpnhiTWAfTR1SzyNBIZTa3gscsiWiR6tw4p5LFWtsiTYrYLXsL1h0iZ3QA67PJ_ux7_4MHoXmaJG2iThSLYc0wKhgifx51JQrFijP0PQOciztCRuZfcPcqWfNKxNY7wvG9__gR3oe7LfomW426PIA1Wz6Ejf2WX_AIzrCVt6nJvCQ5qsPiI1GkqZlC8OZIVRCHmIkn-LedwnDsGE8j2N35XF3UZFmRn3apMFlrnpM-P5So0pCe2U8Wtkbw7rZ5DAc3cdNPYFBWpX0KJBFxaizXKsO-ADTV1jjQaKhbS2dWJAGMOgmReVu1HZuHHEvPHoiFbKRKOqmSXqqkCOB9f85JU7Pk2tlfUPD6mVhv3A9Uix-yNV-S29g4KMoRoDLFmBaInZVycI_bSLMA3jixXVljZ2tP4lgUZynmZ5-NAtjs5FK2lrKWl0IZwOv-sLNxGLhSpa1Omzkpw2KRAfAVbVjZcfVIOT_y1dKz2F1yGgXwodOby83__VSeXX-tr2DDqY7cm0x3n8Md6lUaaUSbMFguTu0LuJ2fLef14mVrFQjIG1aiP8HhoZE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lipids+in+cancer%3A+a+global+view+of+the+contribution+of+lipid+pathways+to+metastatic+formation+and+treatment+resistance&rft.jtitle=Oncogenesis+%28New+York%2C+NY%29&rft.au=Vasseur%2C+Sophie&rft.au=Guillaumond%2C+Fabienne&rft.date=2022-08-09&rft.issn=2157-9024&rft.eissn=2157-9024&rft.volume=11&rft.issue=1&rft.spage=46&rft_id=info:doi/10.1038%2Fs41389-022-00420-8&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-9024&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-9024&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-9024&client=summon